Personal information

Italy

Activities

Employment (1)

UNIVERSITA' DEGLI STUDI L'AQUILA: L'Aquila, Abruzzo, IT

2018-04-26 to 2018-09-25 | Borsisti (Dipartimento di Scienze cliniche applicate e biotecnologiche)
Employment
Source: check_circle
Università degli Studi dell'Aquila - IRIS

Works (19)

Correction: Gravina et al. ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma. Cancers 2022, 14, 289

Cancers
2024-08-21 | Journal article
Contributors: Giovanni Luca Gravina; Alessandro Colapietro; Andrea Mancini; Alessandra Rossetti; Stefano Martellucci; Luca Ventura; Martina Di Franco; Francesco Marampon; Vincenzo Mattei; Leda Assunta Biordi et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

ATX-101, a Peptide Targeting PCNA, Has Antitumor Efficacy Alone or in Combination with Radiotherapy in Murine Models of Human Glioblastoma

Cancers
2022-01-07 | Journal article
Contributors: Giovanni Gravina; Alessandro Colapietro; Andrea Mancini; Alessandra Rossetti; Stefano Martellucci; Luca Ventura; Martina Di Franco; Francesco Marampon; Vincenzo Mattei; Leda Biordi et al.
Source: check_circle
Crossref

Crocetin and crocin from saffron in cancer chemotherapy and chemoprevention

2020-01-01 | Journal article
EID:

2-s2.0-85065760448

WOSUID:

WOS:000467209600007

Source: check_circle
Università degli Studi dell'Aquila - IRIS

Crocetin extracted from saffron shows antitumor effects in models of human glioblastoma

2020-01-01 | Journal article
EID:

2-s2.0-85077847784

WOSUID:

WOS:000515380000053

Source: check_circle
Università degli Studi dell'Aquila - IRIS

Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8)

2019-01-01 | Other
EID:

2-s2.0-85069740265

WOSUID:

WOS:000482838100023

Source: check_circle
Università degli Studi dell'Aquila - IRIS

The brain penetrating and dual TORC1/TORC2 inhibitor, RES529, elicits anti-glioma activity and enhances the therapeutic effects of anti-angiogenetic compounds in preclinical murine models

2019-01-01 | Journal article
EID:

2-s2.0-85074954602

WOSUID:

WOS:000498826000201

Source: check_circle
Università degli Studi dell'Aquila - IRIS

Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6)

2018-01-01 | Journal article
EID:

2-s2.0-85043781457

WOSUID:

WOS:000427729900001

Source: check_circle
Università degli Studi dell'Aquila - IRIS

UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice

2018-01-01 | Journal article
EID:

2-s2.0-85046861069

Source: check_circle
Università degli Studi dell'Aquila - IRIS

Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model

2017-01-01 | Journal article
EID:

2-s2.0-85026359018

WOSUID:

WOS:000406727700023

Source: check_circle
Università degli Studi dell'Aquila - IRIS

The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma

2017-01-01 | Journal article
EID:

2-s2.0-85008463179

WOSUID:

WOS:000391760400002

Source: check_circle
Università degli Studi dell'Aquila - IRIS

Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models

2016-01-01 | Journal article
EID:

2-s2.0-84938149368

WOSUID:

WOS:000374576200037

Source: check_circle
Università degli Studi dell'Aquila - IRIS

CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models

2015-01-01 | Journal article
EID:

2-s2.0-84937459791

WOSUID:

WOS:000358494600001

Source: check_circle
Università degli Studi dell'Aquila - IRIS

EPHRIN A2 ANTAGONISM REDUCES SURVIVAL OF PROSTATE CANCR CELLS AFTER CHEMOTHERAPIC TREATMENTS AND ANGIOGENESIS IN PROSTATE CANCER CELLS BOTH IN VITRO AND IN VIVO

2015-01-01 | Conference paper
WOSUID:

WOS:000355273800160

Source: check_circle
Università degli Studi dell'Aquila - IRIS

Fertility preservation in cancer patients: attenuation of chemotherapy-induced ovarian damage by oral administration of phytochemical carotenoids in an animal model.

2015-01-01 | Journal article
Source: check_circle
Università degli Studi dell'Aquila - IRIS

Prevention of chemotherapy-induced gonadotoxicity in the mouse model: protective effects of natural bioactive compounds

2015-01-01 | Other
WOSUID:

WOS:000359740302144

Source: check_circle
Università degli Studi dell'Aquila - IRIS

Possible involvement of SIRT1 and FOXO3a in oxidative stress response and aging of human granulosa cells

2012-01-01 | Other
WOSUID:

WOS:000325299600582

Source: check_circle
Università degli Studi dell'Aquila - IRIS

Possible role or SIRT 1in human ovarian granulosa cells

2011-01-01 | Other
WOSUID:

WOS:000292333102006

Source: check_circle
Università degli Studi dell'Aquila - IRIS

Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome

2007-01-01 | Journal article
EID:

2-s2.0-40149100521

WOSUID:

WOS:000253502000010

Source: check_circle
Università degli Studi dell'Aquila - IRIS

Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndrome

2004-01-01 | Journal article
EID:

2-s2.0-3242780148

WOSUID:

WOS:000222745600051

Source: check_circle
Università degli Studi dell'Aquila - IRIS